Abstract
A controlled release pharmaceutical composition comprising
a strontium salt. The invention also relates to the use of a
strontium salt for treating a male suffering from diseases and
conditions affecting metabolism and/ or structural integrity of
cartilage and/or bone. The invention also relates to the use of
a strontium-containing compound for preventing a cartilage
and/or bone condition in a subject, and for the treatment
and/or prophylaxis of secondary osteoporosis.
a strontium salt. The invention also relates to the use of a
strontium salt for treating a male suffering from diseases and
conditions affecting metabolism and/ or structural integrity of
cartilage and/or bone. The invention also relates to the use of
a strontium-containing compound for preventing a cartilage
and/or bone condition in a subject, and for the treatment
and/or prophylaxis of secondary osteoporosis.
| Original language | English |
|---|---|
| Patent number | US 2009/0191282 A1 |
| Filing date | 12/22/08 |
| Publication status | Published - Jul 30 2009 |